APA (7th ed.) Citation

E, K., B, Z., A, T., M, H., WW, J., & GW, B. (2026). Successful use of ruxolitinib in steroid-refractory chronic GvHD affecting central nervous system: A case report. Annals of hematology, 105(7), . https://doi.org/10.1007/s00277-026-07064-3

Chicago Style (17th ed.) Citation

E, Karakulska-Prystupiuk, Zakrzewska-Pniewska B, Tomaszewska A, Hałaburda-Rola M, Jędrzejczak WW, and Basak GW. "Successful Use of Ruxolitinib in Steroid-refractory Chronic GvHD Affecting Central Nervous System: A Case Report." Annals of Hematology 105, no. 7 (2026). https://doi.org/10.1007/s00277-026-07064-3.

MLA (9th ed.) Citation

E, Karakulska-Prystupiuk, et al. "Successful Use of Ruxolitinib in Steroid-refractory Chronic GvHD Affecting Central Nervous System: A Case Report." Annals of Hematology, vol. 105, no. 7, 2026, https://doi.org/10.1007/s00277-026-07064-3.